Minocycline-Induced Fixed Drug Eruption of the Lips.

First Reported Case of Treosulfan-Induced Fixed Drug Eruption.

Wine-induced fixed drug eruption.

Nimesulide-Associated Generalized Bullous Fixed Drug Eruption: A Rare Pharmacovigilance Case Report.

Fixed food eruption due to shellfish.

Absence of Cross-Reactivity Between Ornidazole and Metronidazole in Fixed Drug Eruption Demonstrated by Lesional and Contralateral Patch Testing and Oral Provocation.

Internal organ involvement in epidermal necrolysis and bullous fixed drug eruption assessed by 18Fluorodeoxyglucose-positron emission tomography and computed tomography scan. A proof-of-concept study.

Fixed Drug Eruptions in Malagasy Children: Clinical Observations and Characteristics.

Fluconazole-Induced Fixed Drug Eruption With Cross-Reactivity to Clotrimazole-Confirmation With Patch Testing.

Generalized Bullous Fixed Drug Eruption: A Systematic Review.

Inclisiran-Induced Fixed Drug Eruption in a Patient With Refractory Hypercholesterolemia.

Doxycycline-induced fixed drug eruption: A case series highlighting a dermatological concern in antimicrobial stewardship.

Bullous Fixed Drug Eruption Associated With Atenolol: A Rare Dermatological Reaction With Mucosal Involvement.

Etoricoxib-Induced Fixed Erythema.

Feasibility of gadolinium contrast use in transcatheter aortic valve implantation: a non-iodine-based procedure-case report.

Bullous fixed drug eruption associated with ibuprofen.

A Case of Generalized Fixed Drug Eruption Showing the Conjunctival Involvement With CD4+ Tissue-Resident Memory T Cell Accumulation.

Fixed drug eruption induced by clarithromycin and paracetamol in a child.

Delayed hypersensitivity reaction to penicillin can be lost (and gained): Skin test resensitization following prolonged oral provocation test.

Multifocal bullous fixed-drug eruption caused by etodolac mimicking autoimmune bullous diseases: a case report.

Clues From Strange New Antigens: How Skin Responds to Nonself.

Drug-induced fixed urticaria because of hypersensitivity to non steroidal anti-inflammatory drugs.

Skin-adverse drug reactions in the elderly: An underestimated and avoidable issue.

Generalized Bullous Fixed Drug Eruption Secondary to Levocetirizine: A Lesson Learned!

Generalized bullous fixed drug eruption related to intravenous contrast.

Allopurinol-Associated Bullous Fixed Drug Eruption With Cross-Reaction to Febuxostat.

Fixed drug eruption misdiagnosed as herpes simplex virus infection.

Generalized fixed drug eruptions in skin of color.

Localized bullous drug reaction to cefotaxime leading to wet gangrene in a neonate: A case report.

Bullous Non-Pigmenting Fixed Drug Eruption.

Bullous Fixed Drug Eruption to Metformin Following a DRESS Syndrome to Allopurinol: What's the Link?

Clinical Characteristics of Adult Localized and Generalized Fixed Drug Eruptions: A Systematic Review.

Generalized Bullous Fixed Drug Eruption Induced by Chlordiazepoxide: A Case Report of a Potentially Lethal Adverse Effect.

The Use of Etanercept in the Palliative Treatment of a Patient With Generalised Bullous Fixed Drug Eruption.

Skin Testing for the Exploration of Immediate and Delayed Hypersensitivity to Fluoroquinolones: Insights From a Real-Life Cohort Study.

Fixed Drug Eruption With Isotopic Response.

A Fatal Case of Infection-Induced Neurofibromatosis Type 1 in an Adult.

A simple patch test (empty tablet cover patch test) demonstrating ornidazone as offending agent in a patient of fixed drug eruption: Report of a clinical case, a new modified technique and systematic review of literature.

Association Between HLA-A*02:07 and Fixed Drug Eruption Caused by Sulfamethoxazole-Trimethoprim.

Fluoroquinolone-induced generalised fixed drug eruption: a rare clinical image.

A case of recurrent fixed drug eruption triggered by a hormonal intrauterine device.

Levofloxacin-Induced Generalized Fixed Drug Eruption.

Lichen planus pigmentosus inversus presenting with clinical features mimicking acanthosis nigricans.

Accelerated Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome in Response to TMP-SMX: A Case Report.

Adverse Cutaneous Reactions to Monoclonal Antibodies: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Erythema Multiforme, and Fixed Drug Eruption - A Systematic Review.

Mental health and psychosocial outcomes in survivors of severe cutaneous adverse reactions: a scoping review.

Fixed drug eruption induced by Etoricoxib in Thailand: A case report.

Cross-Reactivity: a Case of Paracetamol-Induced Generalized Bullous Fixed Drug Eruption Followed by Dipyrone-Induced Fixed Drug Eruption.

Fixed drug eruption in a cribriform pattern: an atypical presentation.

Demographics, Overlap, and Latency of Severe Cutaneous Adverse Reactions in an FDA Database.

Tissue-resident memory T cells and their function in skin diseases.

Generalized bullous drug eruption triggered by ceftriaxone: a case report and literature overview.

[Exanthematic drug eruption].

Systematic review: characteristics of myocarditis followed by fixed drug eruption and dry eye syndrome in patients who have been vaccinated with monkeypox in children and adults.

Intradermal Tranexamic Acid Injections: A Potential Therapy for Complex Cases of Drug-Induced Postinflammatory Hyperpigmentation.

Vulval fixed drug eruption following trimethoprim use.

Semaglutide-induced fixed drug eruption.

Ibuprofen-Induced Multiple Fixed Drug Eruption Confirmed by Re-Challenge: A Case Report and Literature Review.

Norfloxacin-Induced Penile Fixed Drug Eruption.

Fixed Drug Eruption due to Chlorpheniramine: Case Report.

Clinical cues for distinguishing bullous fixed drug eruption from Stevens-Johnson syndrome: A case report.

Fixed Drug Eruption-Induced Hyperpigmentation Treated With High-Fluence Picosecond Alexandrite Laser.

A review on toxic epidermal necrolysis-like superficial wound lesions: Issue and challenge on 10 clinical entities.

Generalized bullous fixed drug eruption.

Atypical Presentation of Rapidly Progressive Cutaneous Metastases of Clear Cell Renal Carcinoma: A Case Report.

Caffeine-induced fixed drug eruption: evidence from a positive patch test.

[Translated article] AEDV Expert Document on the Management of Ulcerative Venereal Infections.

Oral lichen planus-like lesions in skin of color: a review.

Chloroquine-Induced Fixed Drug Eruption: A Case Report.

Fixed drug eruption and generalized bullous fixed drug eruption: Insights from an analysis of the FDA Adverse Event Reporting System.

Fixed drug eruption due to ibuprofen.

Generalized Fixed Drug Eruption Secondary to Etoricoxib.

Distinguishing Generalized Bullous Fixed Drug Eruption From SJS/TEN: A Retrospective Study on Clinical and Demographic Features.

Chlorzoxazone-Induced Fixed Drug Eruption: A Clinical Case Report.

Fixed Drug Eruption on the Penis Due to Trimethoprim-Sulfamethoxazole: A Case Report.

Generalized Fixed Drug Eruptions Require Urgent Care: A Case Series.

Pseudoephedrine-induced Fixed Drug Eruption in a Scuba Diver With Recurrent Palmoplantar Exfoliation.

Lessons From Delayed Intradermal Testing: A Case of Fixed Drug Eruption From Intra-Articular Methylprednisolone.

Doxycycline-induced fixed drug eruption: The new epidemic?

Fixed drug eruption mimicking syphilitic balanitis of Follmann.

Fixed Drug Eruption to Levocetirizine Detected by Patch Testing.

Delayed Skin Testing for Systemic Medications: Helpful or Not?

A case of fixed drug eruption caused by allylisopropylacetylurea and bromovalerylurea in the same lesion.

Fixed drug eruption secondary to etoricoxib.

Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design.

Severe cutaneous adverse reactions.

Fixed Drug Eruption due to Dupilumab.

Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens.

A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.

Fixed drug eruption due to tipepidine hibenzate and garenoxacin mesylate hydrate: an unusual case of polysensitivity.

A Clinico-Epidemiological Study of Fixed Drug Eruption with a Special Focus on the Causative Agent and the Clinical Patterns.

Nimesulide-Induced Fixed Drug Eruption Followed by Etoricoxib-Induced Fixed Drug Eruption: An Unusual Case Report and Review of the Literature.

A Saudi Woman with Ceftriaxone Induced Fixed Drug Eruption.

Erythema Multiforme-Like Fixed Drug Eruption During Azathioprine and Hydroxychloroquine Treatment for Systemic Lupus Erythematosus Mimicking Rowell Syndrome: A Rare and Challenging Clinical Scenario.

Multiple widespread fixed drug eruption caused by in a transdermal therapeutic system.

Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.

Anaphylactic Shock After Intramuscular Diclofenac Sodium: A Case Report.

Cefepime-Induced Generalized Fixed Drug Eruption With Morbilliform Rash.

Dose-dependent, non-pigmenting fixed drug eruption with eczematous lesions induced by bosutinib: case report.

A case of bullous fixed drug eruption caused by tadalafil.

Genital Ulcers Are Not Always Because of Sexually Transmitted Infections: A Case Report of an Unusual Presentation of Fixed Drug Eruption in a Pediatric Patient.

Triggers, clinical manifestations and assessment of paediatric fixed drug eruptions: A systematic review of the literature.

Paracetamol-induced generalized fixed-drug eruption with localized bullous variant in a 15-year-old boy.

Patch test with multiple antipyretics in a case of fixed drug eruption in a child.

Fixed drug eruption-induced balanoposthitis: a case report.

Bullous fixed drug eruption due to ivermectin.

Fixed Drug Eruption Caused by Garenoxacin: A Case Report and Literature Review.

Recurrent Fluconazole-Induced Fixed Drug Eruption of the Digit with Nail Matrix Involvement: A Case Report and Review of the Literature.

Mucosal Fixed Drug Eruption with Oral, Conjunctival, Nasal, and Anal Lesions: A Case Report.

Fixed drug eruption caused by iodinated contrast media: An unusual hypersensitivity reaction.

Azithromycin-Induced Generalized Nonbullous Fixed-Drug Eruption.

A case of nonpigmented fixed-drug eruption with eosinophilic intraepidermal vesicle formation.

Drug eruptions and the vulva.

Ofloxacin-Induced Genital Bullous Fixed Drug Eruption: A Rare Case of Cross-Reactivity to Multiple Fluoroquinolones.

Chlorthalidone-Induced Fixed-Drug Eruption: Unmasking an Uncommon Reaction to a Common Diuretic.

In Situ Patch Test and Repeated Open Application Test for Fixed Drug Eruption: A Multicenter Study.

Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir.

Reflectance confocal microscopy as a complementary diagnostic tool for greyish-brown dermatoses in children.

Carbamazepine-induced bullous fixed drug eruption: A case report.

Genotypic and Phenotypic Characteristics of Co-Trimoxazole-Induced Cutaneous Adverse Reactions.

Fixed drug eruption - Experience from a tertiary care center in Uttarakhand.

Fixed Drug Eruptions With Flavoured Liquid Formulations of Over-the-Counter Analgesics: A Case Report.

Erythematous-violaceous and bullous skin lesions after administration of iodinated contrast in a patient on hemodialysis. A case of fixed drug eruption due to iodinated contrast.

IFN-γ ELISpot-enabled machine learning for culprit drug identification in nonimmediate drug hypersensitivity.

Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis.

Patch Testing to the Rescue! Lesional Testing for Diagnosis of Fixed Drug Eruption to Pamabrom.

Neutrophilic fixed drug eruption, a histopathologic variant or an expected finding?-A report of two cases and review of the literature.

Tadalafil-Induced Generalized Bullous Fixed Drug Eruption: A Rare Side Effect of a Common Drug.

Metronidazole Induced Cutaneous Adverse Drug Reaction- A Systematic Review of Descriptive Studies.

Generalised bullous fixed drug eruption induced by a topical plaster with Chinese herbs.

Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactions.

A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.

Rapidly progressing generalized bullous fixed drug eruption after the first dose of COVID-19 messenger RNA vaccination.

Photobiomodulation Therapy for Multiple Painful Fixed Drug Eruptions: The First Case Report.

MULTIFOCAL FIXED DRUG ERUPTION MIMICKING ACQUIRED DERMAL MELANOCYTOSIS.

Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review.

A Fixed-Dose Combination of Ofloxacin-Ornidazole Induced Fixed Drug Eruption: A Case Report.

Nicorandil-Induced Bullous Fixed Drug Eruption on the Glans Penis.

Successful treatment of hyperpigmentation from fixed drug eruption with a low-dose and large-spot Q-switched 1064 nm Nd:YAG Laser.

Fixed drug eruption: the often forgotten cutaneous adverse drug reaction.

Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators.

An Observational Study of Fixed Drug Eruption in A Tertiary Care Hospital in Bangladesh.

Novel cutaneous eruptions in the setting of programmed cell death protein 1 inhibitor therapy.

Possible Plasticity of Cytotoxic Resident Memory T Cells in Fixed Drug Eruption.

A case of fixed drug eruption from cetirizine with cross-reaction to levocetirizine and hydroxyzine.

Fixed drug eruption to aripiprazole, cetirizine, and hydroxyzine hydrochloride.

Generalized fixed drug eruption following Pfizer-BioNtech COVID-19 vaccination.

Case report: Severe non-pigmenting fixed drug eruption showing general symptoms caused by chondroitin sulfate sodium.

Uncommon variants of fixed drug eruption.

Cutaneous adverse drug eruption: the role of drug patch testing.

Cross-reactivity between nonsteroidal anti-inflammatory drugs in fixed drug eruption: Two unusual cases and a literature review.

Fixed drug eruptions - the common and novel culprits since 2000.

Hypopigmented penile fixed drug eruption.

Nicotine-induced bullous fixed drug eruption.

A case of recurrent fixed drug eruption following the administration of 2 different coronavirus disease 2019 vaccines verified using intradermal and patch tests.

Fixed Drug Eruption: An Underrecognized Cutaneous Manifestation of a Drug Reaction in the Primary Care Setting.

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR).

Drugs and the skin: A concise review of cutaneous adverse drug reactions.

Sulphamethoxazole-trimethoprim induced fixed drug eruption in a patient with Chronic Granulomatous Disease.

Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020.

Generalized Bullous Fixed Drug Eruption to Iodinated Contrast Media in Skin of Color.

Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19.

Common pitfalls and bias learned from the COVID-19 pandemic: Keeping a clear mind of judgment.

Fixed drug eruption after the Sinopharm COVID-19 vaccine.

A Fixed Drug Eruption to Medroxyprogesterone Acetate Injectable Suspension.

A case of paracetamol-induced nonpigmented fixed drug eruption confirmed by a lymphocyte transformation test.

Reprint of: Fixed-Drug-Eruption associated with NSAID exposure.

Severe Cutaneous Adverse Drug Reactions in Children: Epidemiological, Clinical and Etiological Aspects in Dermatology-Venereology Unit at National and Teaching Hospital of Cotonou.

Fixed drug eruption due to clindamycin with tolerance to lincomycin.

Fixed drug eruption from atezolizumab.

Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report.

Ecstasy-induced fixed drug eruption.

Oral fixed drug eruption: Analyses of reported cases in the literature.

Angioedema and fixed drug eruption simultaneously induced by naproxen sodium: A rare clinical entity.

Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19).

Multifocal Bullous Fixed Drug Eruption.

Fixed Drug Eruption Associated with Nonsteroidal Anti-Inflammatory Drugs for Menstrual Pain: A Case Report.

A Case of Mucosal Fixed Drug Eruption Caused by Tamsulosin Administration.

Mucosal fixed drug eruption to levetiracetam with early positive patch test on non-lesional skin.

Fixed drug eruption in a patient of HLA-B*58:01 negative after allopurinol administration: A case report.

The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications.

Neutrophils in Fixed Drug Eruptions: Correction of a Mistaken Hypothesis.

Cutaneous Adverse Drug Reactions in a Tertiary Teaching Hospital: A Prospective, Observational Study.

Bizarre Cutaneous Ulcers due to Self-Administered Intravenous Dexketoprofen Trometamol.

Annular lichenoid diseases.

Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole.

The Initial Stage of Neutrophilic Dermatosis of the Dorsal Hands: A Case Report and Discussion of Differential Diagnoses.

Fixed Drug Eruption Secondary to Four Anti-diabetic Medications: An Unusual Case of Polysensitivity.

A Study of Cutaneous Adverse Drug Reactions and their Association with Autoimmune Diseases at a Tertiary Centre in South-West Rajasthan, India.

Bullous Erythema Multiforme Secondary to Trimethoprim-Sulfamethoxazole Use, Treated With Cyclosporine in a 91-Year-Old Male.

Hyperpigmentation From Fixed Drug Eruption Successfully Treated With a Low-Fluence 1064 nm Nd:YAG Picosecond Laser.

Analysis of severe cutaneous adverse reactions (SCARs) in Taiwan drug-injury relief system: 18-year results.

Patch testing versus interferon-gamma release assay in evaluation of drug eruptions.

Multiple fixed drug eruption due to carbocysteine: Presence of circulating interferon-γ-producing CD8+ T cells reactive with its night metabolite thiodiglycolic acid.

Vulvar and areolar fixed drug eruption.

A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption.

Skin Resident Memory T Cells May Play Critical Role in Delayed-Type Drug Hypersensitivity Reactions.